Pancreatic Cancer Research

ResearcherVeterans Health AdministrationActive in the last 2 years

Sushanta K. Banerjee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7698-0717; OpenAlex author ID A5038008974. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 3 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic cancer cells. Co-author DOI 10.1016/j.omton.2025.201047↗
  2. pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells … Last author DOI 10.1371/journal.pone.0297749↗
  3. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.0c00499↗
  4. Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer. Co-author DOI 10.1007/s12079-019-00514-w↗
  5. CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-18-0899↗
  6. Cyr61/CCN1 targets for chemosensitization in pancreatic cancer. Last author DOI 10.18632/oncotarget.26986↗
  7. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling. Co-author DOI 10.1074/jbc.ra117.000333↗
  8. Human pancreatic cancer progression: an anarchy among CCN-siblings. Co-author DOI 10.1007/s12079-016-0343-9↗
  9. The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression. Last author DOI 10.3390/ijms17060809↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Snigdha Banerjee · 9 shared papers, 2016–2025 · strength 1.05
  2. Arnab Ghosh · 7 shared papers, 2016–2024 · strength 0.72
  3. Mohiuddin Quadir · 4 shared papers, 2019–2025 · strength 0.63
  4. Debasmita Dutta · 3 shared papers, 2021–2025 · strength 0.54
  5. Priyanka Ray · 3 shared papers, 2019–2024 · strength 0.41
  6. Sanku Mallik · 3 shared papers, 2019–2021 · strength 0.29
  7. Daniel J. Mettman · 1 shared paper, 2025 · strength 0.22
  8. Stefan H. Bossmann · 1 shared paper, 2025 · strength 0.22
  9. Gargi Maity · 3 shared papers, 2016–2019 · strength 0.21
  10. Gauthami Nair · 2 shared papers, 2019–2021 · strength 0.21
  11. Katie M. Reindl · 2 shared papers, 2019–2021 · strength 0.21
  12. Daniel D. Von Hoff · 2 shared papers, 2016–2019 · strength 0.14
  13. Megan Orr · 1 shared paper, 2021 · strength 0.11
  14. Amlan Kumar Das · 1 shared paper, 2019 · strength 0.08
  15. Zuhair Hawa · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.